Status:
RECRUITING
Experiences of Anger in Patients in Primary Health Care With Symptoms of Generalized Anxiety
Lead Sponsor:
Kronoberg County Council
Collaborating Sponsors:
Linnaeus University
Conditions:
Generalized Anxiety
Anger
Eligibility:
All Genders
18+ years
Brief Summary
Symptoms of generalized anxiety is common in the general population and is often treated in primary health care. Anger is an emotion that can lead to interpersonal problems but can also be an agent fo...
Detailed Description
Symptoms of generalized anxiety is common in the general population and is often treated in primary health care. The core of the diagnostic criteria for generalized anxiety disorder (GAD) is excessive...
Eligibility Criteria
Inclusion
- Patients with symptoms of generalized anxiety
- Clinically significant level of symptoms of generalized anxiety which is confirmed by a self-rated diagnose of GAD on the questionnaire GAD-Q-IV (Newman et al., 2002; Moore et al., 2014). The questions of the GAD-Q-IV correspond to the A, B, C and D criteria of GAD in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).
- Sufficient knowledge in Swedish to be able to answer questionnaires and take part in an interview.
- If the patient receives any medical or psychological treatment for generalized anxiety this should be recently started and/or not yet have led to any notable decrease of symptoms. In the case of pharmacological treatment this should not be associated with more extensive psychological side-effects.
Exclusion
- Severe psychiatric difficulties where the patient needs specialized psychiatric care
- Known brain-injury or symptoms of dementia
- The patient is in an acute crisis
- Obvious alcohol or substance abuse
- Health care professionals
- Inclusion Criteria:
- Have a health care profession and work at a primary health care center.
- Current working experience of at least one year at a primary health care center which included contact with patients with symptoms of generalized anxiety
Key Trial Info
Start Date :
October 19 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04702711
Start Date
October 19 2020
End Date
December 1 2026
Last Update
April 16 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Region Kronoberg
Vaxjo, Sweden